Searched for
GENERIC MEDICATIONS FROM INDIA
These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...
Operation Amistad: India reiterates commitment to stand by earthquake-hit VenezuelaIndia has reaffirmed its commitment to Venezuela through Operation Amistad, offering support following devastating twin earthquakes. While ...
Why CDSCO and BEE have not kept pace with the industries they overseeCDSCO still faces challenges like chronic understaffing, gaps in technical skills, weak lab infra and fragmented approvals. About a decade ...
Born on July 1, died on July 1: Who was Dr Bidhan Chandra Roy, in whose memory India celebrates National Doctors' Day?India observes National Doctors' Day on July 1, honoring medical professionals and commemorating the remarkable life of Dr. Bidhan Chandra ...
'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...
Indian Army field hospital begins operations in quake-hit VenezuelaIn response to the catastrophic earthquakes in Venezuela, India's Operation Amistad is delivering vital medical assistance. A fully equippe...
Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval,...
Buying US shares? A complete guide to rules, limits and taxation
From Season 5 release date, cast, and plot: What to expect from final season and what happened in the Season 4 Finale?MGM+'s gripping horror series 'From' is gearing up for its fifth and final season in 2027, promising to unravel the town's deepest secrets....
Health ministry proposes faster approvals for medical device manufacturing licencesThe Union health ministry is proposing to significantly cut down the time taken to issue manufacturing licenses for medical devices. Aimed ...
Indian Air Force C-17s carry relief materials to earthquake-hit Venezuela via Abidjan under OP AmistadIndian Air Force's Boeing C-17 Globemaster aircraft have transited through Cote d'Ivoire's capital city of Abidjan en route to Venezuela ca...
Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
AI platform developed to support doctors, frontline workers with verified health intelligenceA Chennai-based epidemiologist has launched HIVE, an AI-powered platform designed to deliver verified, evidence-based healthcare intelligen...
India dispatches medical contingent to Venezuela amid earthquake crisisIndia has sent a specialized medical team and vital supplies to earthquake-stricken Venezuela. A 41-member contingent from the 60 Para Fiel...
India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...